Phase II Trial of Leronlimab for COVID-19 Enrolls First Patients

CytoDyn announced that it has enrolled and treated the first 2 patients with COVID-19 with leronlimab under its phase II randomized clinical trial.

Source: CancerNetwork - April 9, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news